In a nutshell This study investigated the effects of adding ixazomib (Ninlaro) to lenalidomide (Revlimid) and dexamethasone (Dexasone) for patients with unresponsive multiple myeloma. The main finding was that patients receiving ixazomib plus lenalidomide and dexamethasone survived longer without worsening of cancer (progression-free...
Read More
Home »
Type(s) of combined therapy-IRd
Type(s) of combined therapy-IRd Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Colorectal cancer
- Coronary artery disease
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- Arginine and erectile dysfunction
- Risk of blood clots in breast cancer patients treated with aromatase inhibitors or tamoxifen
- Safety and effectiveness of urinary slings for stress urinary incontinence
- Survival in patients with melanoma treated with pembrolizumab
- Can monitoring minimal residual disease levels in CLL predict outcomes?